People with the most common type of lung cancer whose disease has spread to the brain could be spared potentially harmful whole brain radiotherapy, according to new research published in The Lancet.
The finding could help improve quality of life and cognitive function for many patients diagnosed with brain metastases each year in the United States and beyond. Results from this trial comparing ...
An international clinical study led by the Medical University of Vienna shows that the drug patritumab deruxtecan (HER3-DXd) can have a promising effect in patients with active brain metastases of ...